| Code | 8745D | ||||||||||
| MA number | 18/0262/21-S | ||||||||||
| Product Form: | tbl flm 98x25 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Glenmark Pharmaceuticals s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.10.2021 |
| Validity: | 19.10.2026 |
| SPC: |
SPC_Sitagliptin Glenmark 25mg_50mg_100mg_10_2021.pdf
|
| PIL: |
PIL_Sitagliptin Glenmark 25mg_50mg_100mg_10_2021.pdf
|
| Safety feature | Yes |
| Data update: | 26.10.2021 |
